Michael Rapp - 15 Jan 2023 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
Director
Signature
/s/ Purnanand D. Sarma, Attorney-in-Fact
Issuer symbol
IMNM
Transactions as of
15 Jan 2023
Net transactions value
+$70,000
Form type
4
Filing time
17 Jan 2023, 05:26:58 UTC
Previous filing
21 Jun 2022
Next filing
12 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMNM Common Stock Award $70,000 +17,500 +2.2% $4.00 817,366 15 Jan 2023 Direct F1
holding IMNM Common Stock 208,742 15 Jan 2023 See Footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of Common Stock were issued to the Reporting Person pursuant to the Issuer's 2020 Equity Compensation Plan in lieu of the non-employee director board and committee cash retainers of $70,000 in the aggregate owed to the Reporting Person for service on the board of directors in 2022.
F2 The shares are held by Broadband Capital Investments LLC ("Broadband"). The reporting person is managing member of Broadband and has voting and investment power with respect to shares held by Broadband.